Pamela Klein
Presidente presso I-MAB
Patrimonio netto: 168 792 $ in data 30/04/2024
Profilo
Pamela M.
Klein is the founder and president of Pmk Bioresearch, which was founded in 2008.
She is currently the chairman of I-Mab since 2020, a non-executive director of Patrys Ltd.
since 2019, an independent non-executive director of argenx SE since 2016, an independent director and board member of Ona Therapeutics SL, an independent director and board member of Frontier Medicines Corp.
since 2023, an independent director and board member of Sardona Therapeutics, Inc. since 2023, a venture partner at Ysios Capital Partners SGEIC SA since 2020, and an advisor at Proxenia Venture Partners LLC.
Dr. Klein's former positions include being a research director at the National Cancer Institute from 1995 to 2001, an independent director of F-Star Therapeutics, Inc. (United States) from 2019 to 2020, a director at F-Star Therapeutics, Inc. (United States), a member of the board of directors at F-Star Therapeutics, Inc. (United States) from 2019 to 2020, an independent director of F-star Therapeutics, Inc. from 2020 to 2023, an independent director at Jiya Acquisition Corp., the vice president of development at Genentech, Inc. from 2001 to 2007, the chief medical officer at Syndax Pharmaceuticals, Inc., the chief medical officer at Intellikine LLC from 2008 to 2011, and the chief medical officer at Olema Pharmaceuticals, Inc. from 2018 to 2022.
Dr. Klein obtained a doctorate degree from Stritch School of Medicine in 1992 and another doctorate degree from The California State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 450 ( 0.00% ) | 168 792 $ | 30/04/2024 |
Posizioni attive di Pamela Klein
| Società | Posizione | Inizio |
|---|---|---|
| ARGENX SE | Direttore/Membro del Consiglio | 28/04/2016 |
| PATRYS LIMITED | Direttore/Membro del Consiglio | 01/10/2019 |
| I-MAB | Presidente | 10/02/2024 |
Proxenia Venture Partners LLC
 Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Consulente / Consigliere | - |
| Sardona Therapeutics, Inc. | Direttore/Membro del Consiglio | 01/01/2023 |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Direttore/Membro del Consiglio | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 01/01/2023 |
| Pmk Bioresearch | Fondatore | 01/01/2008 |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investitore di Private Equity | 01/06/2020 |
Precedenti posizioni note di Pamela Klein
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Pamela Klein
| The California State University | Doctorate Degree |
| Stritch School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| PATRYS LIMITED | Health Technology |
| ARGENX SE | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| I-MAB | Health Technology |
| Aziende private | 12 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Finance |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Health Technology |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware. | Finance |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Jiya Acquisition Corp. is a blank check company. The firm was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying promising opportunities in the biopharmaceutical sector. The company was founded in August 2020 and is headquartered in Palo Alto, CA. | Finance |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Sardona Therapeutics, Inc. | |
| Pmk Bioresearch |
- Borsa valori
- Insiders
- Pamela Klein